期刊文献+

羟基化多溴联苯醚(OH-PBDEs)在小鼠肝脏S9中的体外代谢研究 被引量:4

In vitro metabolism of Hydroxylation polybrominated diphenyl ethers in mice liver
原文传递
导出
摘要 羟基化多溴联苯醚(OH-PBDEs)是一类具有内分泌干扰性质的酚类化合物,且内分泌干扰效应大于其母体多溴联苯醚(PBDEs),研究OH-PBDEs的体外代谢行为对于理解其在生物体内的富集转化具有重要意义.以小鼠肝脏S9部分作为研究对象,考察了3-OH-BDE-47、5-OHBDE-47、6-OH-BDE-47和2'-OH-BDE-68在小鼠肝脏中的体外代谢.结果表明小鼠肝脏S9中的I相酶和II相酶均能代谢4种OH-PBDEs;醚键与OH官能团及Br原子互为邻位时,I相酶对OH-PBDEs的代谢率最高,即6-OH-BDE-47表现出较高的代谢率,此外,4种OH-PBDEs经I相酶代谢后均能生成2,4-二溴苯酚,表明醚键断裂是其主要的I相酶代谢途径;OH-PBDEs的OH官能团与醚键互为间位时,II相酶对其葡萄糖醛酸结合反应最高,也就是5-OH-BDE-47表现出较高的去除率. Hydroxylation polybrominateddiphenyl ethers( OH-PBDEs) are a class of phenolic compounds that have endocrine disruption effects,and their biological toxicity is higher than polybrominateddiphenyl ethers( PBDEs). It is of great significance to investigate metabolic behavior of OH-PBDEs in vitro for a better understanding of their enrichment and transformation in vivo. The in vitro metabolism of 3-OH-BDE-47,5-OH-BDE-47,6-OH-BDE-47 and 2’-OH-BDE-68 was investigated using mouse liver S9 fraction. The results showed that four OH-PBDEs can be metabolized by I phase and II phase enzyme. OH-PBDEs with hydroxyl group and bromine adjacent to the etherbond showed faster metabolic rates,i. e. 6-OH-BDE-47 had much faster metabolic rates. In addition,2,4-dibromophenol was detected in the metabolic product of all of the 4 OH-PBDEs by I phase enzyme,suggesting that cleavage of the diphenyl ether bond was the dominant pathway. II phase enzyme was more likely to react with OH-PBDEs with hydroxyl group at meta position than the ether bond,i.e. 5-OH-BDE-47 showed a high removal rate.
出处 《环境科学学报》 CAS CSCD 北大核心 2016年第9期3480-3487,共8页 Acta Scientiae Circumstantiae
基金 国家自然科学基金(No.21407055) 江苏省自然科学基金(No.BK20140115) 中央级公益性科研院所基本科研业务专项(2015)~~
关键词 羟基化多溴联苯醚(OH-PBDEs) 肝脏S9 体外代谢 细胞色素P450酶(CYP450) 尿苷二磷酸葡萄糖醛酸转移酶(UGT) hydroxylated polybrominated diphenyl ethers(OH-PBDEs) liver S9 in vitro metabolism CYP450 UGT
  • 相关文献

参考文献38

  • 1Bastos P M, Eriksson J, Vidarson J, et al. 2008. Oxidative transformation of polybrominated diphenyl ether congeners (PBDEs)and of hydroxylated PBDEs (OH-PBDEs) [ J ]. Environmental Science and Pollution Research, 15(7) : 606-613.
  • 2Bastos P M, Eriksson J, Bergman A. 2009. Photochemical decomposition of dissolved hydroxylated polybrominated diphenyl ethers under various aqueous conditions[J]. Chemosphere, 77(6): 791-797.
  • 3Bolton J L, Trush M A, Penning T M, et al. 2000. Role of quinones in toxicology[J]. Chemical Research in Toxicology, 13(3) : 135-160.
  • 4Cant6n R F, Sanderson J T, Nijmeijer S, a al. 2006. In vitro effects of brominated flame retardants and metabolites on CYPI7 catalytic activity: A novel mechanism of action? [ J ]. Toxicology and Applied Pharmacology, 216(2): 274-281.
  • 5Cant6n R F, Scholten D E A, Marsh G, et al. 2008. Inhibition of human placenta/aromatase activity by hydmxylated polybrominated diphenyl ethers (OH-PBDEs) [ J ]. Toxicology and Applied Pharmacology, 227(1) : 68-75.
  • 6Covaci A, Voorspoels S, Roosens L, et al. 2008. Polybrominated diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs) in human liver and adipose tissue samples from Belgium [ J I. Chemosphere, 73(2) : 170-175.
  • 7Dahlberg A K, Norrgran J, Hovander L, et al. 2014. Recovery discrepancies of OH-PBDEs and polybromophenols in human plasma and cat serum versus herring and long-tailed duck plasma [ J ]. Chemosphere, 94:97-103.
  • 8De la Tone A, Pacepavieius G, Mart~nez M A, etal. 2013. Polybrominated diphenyl ethers and their methoxylated and hydroxylated analogs in Brown Bullhead (Ameiurus nebulosus )plasma from Lake Ontario [ J ]. Chemosphere, 90 ( 5 ) : 1644-1651.
  • 9Erratico C, Zheng X B, Ryden A, et al. 2015. Human hydroxytated metabolites of BDE-47 AND BDE-99 are glucuronidated and sulfated in vitro[J]. Toxicology Letters, 236(2) : 98-109.
  • 10Erratico C A, Szeitz A, Bandiera S M, 2013. Biotransformation of 2,2', 4, 4'-tetrabromodiphenyl ether ( BDE-47 ) by human liver microsomes: identification of cytochrome P450 2B6 as the major enzyme involved [ J 1. Chemical Research in Toxicology, 26 ( 5 ) : 721-731.

二级参考文献49

  • 1任彭,刘兆平.细胞色素P450研究概况及其应用[J].食品与药品,2006,8(10A):8-13. 被引量:17
  • 2任金亮,王平.多溴联苯醚环境行为的特征与研究进展[J].化工进展,2006,25(10):1152-1157. 被引量:34
  • 3Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and ad- verse effects[J]. Am Faro Physician, 2007, 76(3) : 391-396.
  • 4Guengerich FP. Cytochrome P450s and other en zymes in drug metabolism and toxicity[J]. AAPS J, 2006, 8(1): E101-111.
  • 5Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and ad- verse effects[J]. Am Faro Physician, 2007, 76(3): 391.
  • 6Kedderis GL, Lipscomb JC. Application of in vitro biotransformation data and pharmacokinetic model ing to risk assessment[J]. Toxicoi Ind Health, 2001, 17(5/6/7/8/9/10): 315--321.
  • 7Friedberg F, Wolf CR. Merits and limitations of re combinant models for the study of human P450 mediated drug metabolism and toxicity : Am intralaboratory comparison[J]. Drug Metab Rev, 1999, 31 (2) : 523--544.
  • 8Parikh A , Gillam EM , Guengerich FP. Drug metabolism by eseherichis coli expressing human cyto-chromesP450[J]. Nat Biotechnol, 1997, 15 (8): 784--788.
  • 9Pelkonen O, Kaltiala EH, Larmi TK, et al. Cytochrome P-450-1inked monooxygenase system and drug-induced spectral interactions in human liver mierosomes[J]. Chem Biol Interact, 1974, 9(3): 205--216.
  • 10Araya Z, WikvaI1 K. 6-alpha-hydroxylation of tau- rochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes[J].

共引文献19

同被引文献62

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部